Acadian Asset Management
LRMR icon

Acadian Asset Management’s Larimar Therapeutics LRMR Stock Holding History

Acadian Asset Management’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$173K Sell
57,443
-2,038
-3% -$8.09K ﹤0.01% 1664
2026
Q1 		$265K Sell
59,481
-5,189
-8% -$20.7K ﹤0.01% 1512
2025
Q4 		$245K Buy
+64,670
New +$252K ﹤0.01% 1478
2025
Q2 		– Sell
-53,239
Closed -$113K – 1763
2025
Q1 		$113K Buy
+53,239
New +$168K ﹤0.01% 1337
2024
Q1 		– Sell
-22,692
Closed -$103K – 1694
2023
Q4 		$103K Sell
22,692
-13,255
-37% -$44.7K ﹤0.01% 1351
2023
Q3 		$141K Sell
35,947
-91,280
-72% -$345K ﹤0.01% 1252
2023
Q2 		$397K Buy
127,227
+53,804
+73% +$220K ﹤0.01% 1109
2023
Q1 		$331K Buy
+73,423
New +$384K ﹤0.01% 1145
2021
Q3 		– Sell
-457
Closed -$4K – 1884
2021
Q2 		$4K Buy
+457
New +$5.16K ﹤0.01% 1968
2020
Q3 		– Sell
-20,106
Closed -$259K – 2280
2020
Q2 		$259K Buy
+20,106
New +$234K ﹤0.01% 1408
2019
Q4 		– Sell
-14,830
Closed -$131K – 1996
2019
Q3 		$131K Buy
+14,830
New +$163K ﹤0.01% 1420
2019
Q2 		– Sell
-11,806
Closed -$389K – 1948
2019
Q1 		$389K Buy
+11,806
New +$605K ﹤0.01% 1175
2018
Q4 		– Sell
-657
Closed -$92K – 1778
2018
Q3 		$92K Sell
657
-3,438
-84% -$417K ﹤0.01% 1221
2018
Q2 		$502K Sell
4,095
-1,881
-31% -$160K ﹤0.01% 893
2018
Q1 		$534K Sell
5,976
-2,692
-31% -$228K ﹤0.01% 842
2017
Q4 		$481K Buy
8,668
+1,339
+18% +$60.3K ﹤0.01% 808
2017
Q3 		$310K Buy
7,329
+112
+2% +$4.66K ﹤0.01% 850
2017
Q2 		$304K Buy
+7,217
New +$369K ﹤0.01% 900

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Acadian Asset Management's LRMR Position: Q2 2026 in Review

Acadian Asset Management reduced its Larimar Therapeutics (LRMR) stake by 3.4% in Q2 2026, selling an estimated $8.09K and leaving 57,443 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #1664.

Acadian Asset Management first reported a position in LRMR in Q2 2017 and has held it in 18 quarters since. The position peaked at $534K in Q1 2018. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Acadian Asset Management held 57,443 shares of Larimar Therapeutics worth $173K as of Q2 2026.
  • Acadian Asset Management sold 2,038 Larimar Therapeutics shares in Q2 2026, an estimated $8.09K.
  • Larimar Therapeutics made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1664 holding.
  • Acadian Asset Management first reported a position in Larimar Therapeutics in Q2 2017 and has held it in 18 quarters since.
  • Acadian Asset Management's Larimar Therapeutics position peaked at $534K in Q1 2018.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.